First reimbursement for rotational atherectomy systems via LPPR list

07

Oct 2020

On August 6, 2020, the Ministry of Solidarity and Health published an Order (of August 4, 2020) listing the rotational atherectomy systems ROTAPRO and ROTALINK PLUS of the company BOSTON SCIENTIFIC under Title V of the list of reimbursable products and services provided for in Article L. 165-1 of the Social Security Code (LPPR List).

In Title V of the list of reimbursable products and services, Chapter 2, section 5, “Rotational Atherectomy Systems,” was added. It included two codes:

  • 5243374 Rotational Atherectomy System, Boston Scientific, ROTALINK PLUS
  • 5218318 Rotational Atherectomy System, Boston Scientific, ROTAPRO

The indication for the use of ROTAPRO and ROTALINK PLUS is the treatment of native coronary stenosis not expandable by balloon:

  • Either by not crossing a balloon of minimum size
  • Or by non-impaction with a balloon of a size suitable for the artery and inflated at high pressure (up to 30 atm)

The updated version of LPPR list was published on August 27, 2020, at the website of the social security institutions which includes Rotational Atherectomy System ROTAPRO (5218318) and ROTALINK PLUS (5243374) with the tariff of €1,148.4.

See the full details on the Order of the Ministry of Solidarity and Health here, updated LPPR list here

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more

03

Mar 2022

In February 2022, two more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, thirty health apps are now available at the DiGA Directory.

Read more